Clinical Trial Update: MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

View source ↗

Summary

A clinical trial called MAGESTIC is evaluating microRNA biomarkers to detect active malignant testicular germ cell tumors in early suspected and metastatic dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Testicular Germ Cell Tumor

Snippet

Sponsor: University of Southern California | Conditions: Malignant Testicular Germ Cell Tumor | Status: RECRUITING